2025-09-04 - Analysis Report
Okay, here's an analysis of Air Products and Chemicals Inc (APD), incorporating all the provided data points.

**Report: Air Products and Chemicals Inc (APD) Analysis**

**0. Executive Summary**

APD's recent performance has lagged the S&P 500. While historical periods show some outperformance, recent trends indicate underperformance, reflected in the large negative relative divergence and the recent price volatility. News indicates significant events influence the stock with a combination of analyst concern and optimism. Investors should closely monitor company announcements and industry trends.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** APD
*   **Company:** Air Products and Chemicals Inc (supplies industrial gases and equipment globally.)
*   **APD Cumulative Return:** 27.82%
*   **VOO Cumulative Return:** 99.17%
*   **Absolute Divergence (Final Day):** -73.0%
*   **Relative Divergence:** 0.0 (Indicates APD is currently at the lowest end of its historical performance range relative to VOO).

**Alpha/Beta Analysis Table:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
|------------|---------|-------|---------|-------|--------|
| 2015-2017  | 24.0%   | 54.4% | -5.0%   | 0.0   | 36.5   |
| 2016-2018  | 20.0%   | 60.4% | 2.0%    | 0.2   | 35.6   |
| 2017-2019  | 48.0%   | 60.4% | 18.0%   | 0.9   | 52.3   |
| 2018-2020  | 33.0%   | 60.4% | 14.0%   | 0.4   | 60.8   |
| 2019-2021  | 59.0%   | 59.5% | 11.0%   | 0.3   | 67.7   |
| 2020-2022  | 22.0%   | 71.4% | 20.0%   | 0.3   | 68.6   |
| 2021-2023  | -18.0%  | 71.4% | -36.0%  | 0.8   | 60.9   |
| 2022-2024  | -25.0%  | 71.4% | -51.0%  | 0.8   | 64.5   |
| 2023-2025  | -54.0%  | 71.5% | -105.0% | 1.2   | 64.9   |

*   **Analysis:**
    *   The large negative divergence indicates significant recent underperformance compared to the S&P 500.
    *   The relative divergence of 0.0 suggests APD is currently performing near the bottom of its historical range relative to the index.
    *   The Alpha/Beta analysis shows varied performance across different periods. While some periods exhibited strong alpha (outperformance), recent years show significant negative alpha, indicating underperformance even considering market movements (Beta). Beta has also increased recently, suggesting higher volatility relative to the market.

**2. Recent Price Action**

*   **Current Price:** 291.48
*   **Last Market Data:** {'price': 291.48, 'previousClose': 292.19, 'change': -0.24}
*   **5-Day Moving Average:** 293.83
*   **20-Day Moving Average:** 291.79
*   **60-Day Moving Average:** 288.65

*   **Analysis:**
    *   The price closed lower compared to the previous close, indicating a slight downward pressure.
    *   The 5-day moving average is above the 20-day, and the 20-day moving average is above the 60-day, which, in isolation, *could* be interpreted as a short-term bullish trend.  However, the proximity of these averages and the recent price action suggests a period of consolidation or potential further decline.

**3. Technical Indicators and Outlook**

*   **Market Risk Indicator (MRI):** 0.3403 (Low Risk)
*   **RSI:** 53.44 (Neutral)
*   **PPO:** -0.0037 (Slightly Bearish)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe)
*   **Recent (20-day) Relative Divergence Change:** -1.2 (Short-term downward trend)
*   **Expected Return (%):** -1516.6% (Very Negative, suggesting significant underperformance vs. S&P 500 over a long-term investment horizon).

*   **Analysis:**
    *   The MRI suggests low market risk, which is a slightly contrarian signal given the other negative indicators.
    *   The RSI is neutral, not indicating overbought or oversold conditions.
    *   The negative PPO supports a bearish signal.
    *   The significant negative expected return raises concerns about long-term investment prospects relative to the S&P 500.
    *   The negative change in relative divergence confirms recent underperformance.
    *   The price change of -0.24 might reflect a broader market correction or company-specific news.

**4. Recent News & Significant Events:**

*   **2025-09-02:** Major business developments, regulatory changes, or market events.
*   **2025-09-04:** Analysts discussing performance and outlook.
*   **2025-09-03:** Notable stock volatility.
*   **2025-08-31:** Market experts highlighting risks and opportunities, advising monitoring of news and announcements.

*   **Analysis:** The news suggests APD is experiencing significant activity and scrutiny. Investors should carefully research these developments.

**5. Recent Earnings Analysis:**

| Date       | EPS   | Revenue       |
|------------|-------|---------------|
| 2025-07-31 | 3.20  | 3.02 B$       |
| 2025-05-01 | -7.77 | 2.92 B$       |
| 2025-02-06 | 2.77  | 2.93 B$       |
| 2024-08-01 | 3.13  | 2.99 B$       |
| 2025-07-31 | 3.13  | 2.99 B$       |

*   **Analysis:** The earnings data reveals volatility. A significant loss in one quarter (-7.77 EPS) is a concern. While some quarters show positive EPS, the overall trend is mixed. Investors should investigate the reasons behind the EPS fluctuation.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $3.02B   | 32.51%        |
| 2025-03-31 | $2.92B   | 29.57%        |
| 2024-12-31 | $2.93B   | 31.21%        |
| 2024-09-30 | $3.19B   | 33.98%        |
| 2024-06-30 | $2.99B   | 32.82%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE       |
|------------|----------|-----------|
| 2025-06-30 | $15.54B  | 4.59%     |
| 2025-03-31 | $14.70B  | -11.77%    |
| 2024-12-31 | $16.69B  | 3.70%     |
| 2024-09-30 | $17.04B  | 11.45%    |
| 2024-06-30 | $15.10B  | 4.61%     |

*   **Analysis:** The revenue is relatively stable, but the profit margin shows some fluctuation. The ROE is highly variable, with one quarter showing a significant loss. This reinforces the need for a deeper understanding of APD's financial performance.

**7. Overall Assessment**

Based on the provided data, Air Products and Chemicals Inc (APD) is currently facing challenges. While the MRI indicates low risk, other factors suggest caution. The recent performance has lagged behind the S&P 500, and the negative expected return raises concerns about long-term prospects. The volatile earnings and ROE figures also warrant further investigation. The news suggests significant events are influencing the stock. Investors should carefully monitor company announcements and conduct thorough due diligence before making any investment decisions.
